140 related articles for article (PubMed ID: 9928409)
1. CD44 expression in colorectal cancer.
Weg-Remers S; Schüder G; Zeitz M; Stallmach A
Ann N Y Acad Sci; 1998 Nov; 859():304-6. PubMed ID: 9928409
[No Abstract] [Full Text] [Related]
2. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
3. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
Gorham H; Sugino T; Woodman AC; Tarin D
J Clin Pathol; 1996 Jun; 49(6):482-8. PubMed ID: 8763263
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
Kawahara K; Yoshino T; Kawasaki N; Miyake K; Akagi T
J Clin Pathol; 1996 Jun; 49(6):478-81. PubMed ID: 8763262
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma.
Zhang W; Feng Q; Wang C; Zeng X; Du Y; Lin L; Wu J; Fu L; Yang K; Xu X; Xu H; Zhao Y; Li X; Schoenauer UH; Stadlmayr A; Saksena NK; Tilg H; Datz C; Liu X
J Immunol; 2017 May; 198(9):3719-3728. PubMed ID: 28348270
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
Finke LH; Terpe HJ; Zörb C; Haensch W; Schlag PM
Lancet; 1995 Mar; 345(8949):583. PubMed ID: 7539876
[No Abstract] [Full Text] [Related]
8. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
9. CD44s, CD44v5 and CD44v6 protein contents in colorectal cancer and surrounding mucosa.
Llaneza A; Gonzalez A; Andicoechea A; Fernandez JC; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2000; 15(2):192-4. PubMed ID: 10883895
[No Abstract] [Full Text] [Related]
10. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
Yamao T; Matsumura Y; Shimada Y; Moriya Y; Sugihara K; Akasu T; Fujita S; Kakizoe T
Gastroenterology; 1998 Jun; 114(6):1196-205. PubMed ID: 9609756
[TBL] [Abstract][Full Text] [Related]
11. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
12. Multiple intron retention occurs in tumor cell CD44 mRNA processing.
Goodison S; Yoshida K; Churchman M; Tarin D
Am J Pathol; 1998 Oct; 153(4):1221-8. PubMed ID: 9777953
[TBL] [Abstract][Full Text] [Related]
13. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
[TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9.
Tobi M; Maliakkal BJ; Alousi MA; Voruganti V; Shafiuddin M; Yang S; Gesell MS; An T; Hatfield JS; Fligiel S
Scand J Gastroenterol; 1992 Sep; 27(9):737-42. PubMed ID: 1411278
[TBL] [Abstract][Full Text] [Related]
15. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
Shibuya Y; Okabayashi T; Oda K; Tanaka N
Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between glycoprotein antigens appearing in colonic adenoma and colonic adenocarcinoma and those in human fetal colonic mucosa].
Akahona Y; Kawakami Y; Abe T; Yachi A
Nihon Shokakibyo Gakkai Zasshi; 1984 Feb; 81(2):194-200. PubMed ID: 6716703
[No Abstract] [Full Text] [Related]
17. Glycoprotein CD44 variant 4 expression in tumour epithelial cells of patients with colorectal cancer.
Zalewski B; Stasiak-Barmuta A; Sulkowski S; Piotrowski Z; Myśliwiec P; Kukliński A
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():37-9. PubMed ID: 15638368
[TBL] [Abstract][Full Text] [Related]
18. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis.
Yue SQ; Yang YL; Dou KF; Li KZ
World J Gastroenterol; 2003 Dec; 9(12):2863-5. PubMed ID: 14669354
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
[TBL] [Abstract][Full Text] [Related]
20. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
